Q4 2020
|
3 |
359,218 |
FROG, ALIM, BILL
|
13F-HR
|
2/12/2021 |
000095012321001875 |
Q3 2016
|
4 |
45,477 |
Horizon Pharma plc, EVDY, ALIM, Orexigen Therapeutics, Inc.
|
13F-HR
|
11/14/2016 |
000095012316022253 |
Q2 2016
|
4 |
42,243 |
Horizon Pharma plc, EVDY, ALIM, Orexigen Therapeutics, Inc.
|
13F-HR
|
11/14/2016 |
000095012316022247 |
Q1 2016
|
5 |
50,151 |
Horizon Pharma plc, EVDY, ALIM, HUBS
|
13F-HR
|
5/26/2016 |
000095012316017779 |
Q4 2015
|
5 |
65,321 |
Horizon Pharma plc, ALIM, EVDY, HUBS
|
13F-HR
|
3/2/2016 |
000095012316015251 |
Q3 2015
|
5 |
80,466 |
Horizon Pharma plc, HUBS, EVDY, ALIM
|
13F-HR
|
11/18/2015 |
000095012315012308 |
Q2 2015
|
6 |
153,537 |
Horizon Pharma plc, HUBS, EVDY, ALIM
|
13F-HR
|
7/29/2015 |
000095012315007777 |
Q1 2015
|
6 |
200,192 |
HUBS, Horizon Pharma plc, ALIM, Orexigen Therapeutics, Inc.
|
13F-HR
|
6/2/2015 |
000095012315006755 |
Q4 2014
|
6 |
175,093 |
HUBS, Horizon Pharma plc, EVDY, ALIM
|
13F-HR
|
5/19/2015 |
000095012315006624 |